189 related articles for article (PubMed ID: 21159647)
1. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
Majumder S; Roy S; Kaffenberger T; Wang B; Costinean S; Frankel W; Bratasz A; Kuppusamy P; Hai T; Ghoshal K; Jacob ST
Cancer Res; 2010 Dec; 70(24):10265-76. PubMed ID: 21159647
[TBL] [Abstract][Full Text] [Related]
2. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
3. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Shirakami Y; Gottesman ME; Blaner WS
Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
[TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
[TBL] [Abstract][Full Text] [Related]
6. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
7. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
9. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
Maeda S; Kamata H; Luo JL; Leffert H; Karin M
Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis.
Alwahaibi NY; Budin SB; Mohamed J; Alhamdani A
J Gastroenterol Hepatol; 2010 Apr; 25(4):786-91. PubMed ID: 20492335
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
12. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
[TBL] [Abstract][Full Text] [Related]
14. Augmented humoral immune function in metallothionein-null mice.
Crowthers KC; Kline V; Giardina C; Lynes MA
Toxicol Appl Pharmacol; 2000 Aug; 166(3):161-72. PubMed ID: 10906280
[TBL] [Abstract][Full Text] [Related]
15. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.
Khan MS; Devaraj H; Devaraj N
Toxicol Appl Pharmacol; 2011 Feb; 251(1):85-94. PubMed ID: 21167192
[TBL] [Abstract][Full Text] [Related]
16. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
[TBL] [Abstract][Full Text] [Related]
17. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effect of vanadium in a rodent model of chemical hepatocarcinogenesis: reflections in oxidative DNA damage, energy-dispersive X-ray fluorescence profile and metallothionein expression.
Chakraborty T; Chatterjee A; Saralaya MG; Chatterjee M
J Biol Inorg Chem; 2006 Oct; 11(7):855-66. PubMed ID: 16830150
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
[TBL] [Abstract][Full Text] [Related]
20. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
